Expert Discusses Key Developments in Breath Biopsy
Owlstone Medical CEO discusses recent trends, the advantages of breath testing, and the challenges that must be met for wider clinical use.
Expert Q&A: The Latest in Breath Biopsy
Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.
This content is for Paid Members only.
Register
Register
Already a member? Log in here
FDA Issues First Approval for SARS-CoV-2 Breathalyzer Test
InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.
This content is for Paid Members only.
Register
Register
Already a member? Log in here
InspectIR Nabs First FDA Approval for a SARS-CoV-2 Breathalyzer
On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.
This content is for Paid Members only.
Register
Register
Already a member? Log in here
